Navigation Links
A Finnish Company Enters International Markets With World Class Genetics Technology

HELSINKI, June 12, 2013 /PRNewswire/ --

Blueprint Genetics has launched a new genetic testing technology for professional use in hospitals. The gene sequencing technology is based on Stanford University research and can effectively analyse rare hereditary human diseases. The company started its operations in 2012 in Helsinki.

The tests of Blueprint Genetics enable efficient diagnosis of difficult hereditary diseases. Today there are almost 4000 recognized diseases with a genetic background. The results of genetic tests will help physicians in reaching their diagnoses, predicting the course of the disease, choosing treatments, and efficient screening of relatives. The first tests of Blueprint Genetics focus on hereditary cardiovascular diseases.

The company aims to bring genetic diagnostics into the daily routines of healthcare organizations by lowering the barrier to start using genetic testing. This will be enabled by offering tests that are more comprehensive, more cost-effective and faster than existing tests. The geneticists and clinicians at Blueprint Genetics will interpret the test results and give statements directly to the treating physicians within three weeks from sample reception.

Blueprint Genetics targets international diagnostics markets and will begin its operations in the EU area. The international recommendations for the use of genetic diagnostics are increasing rapidly and current research advocates comprehensive testing for hereditary diseases. According to Blueprint Genetics, there have never been so comprehensive, or easy-to-use tests available for a price level that is feasible for clinical use.

The company has a strong background in medical genetics research. "Finland is a great place to start an international genetics growth company. We have a huge amount of knowledge and resources in Finland and the genetics research is globally recognized," says Tommi Lehtonen, CEO of Blueprint Genetics.

Blueprint Genetics provides advanced professional genetic testing for rare diseases. The company started its operations in 2012 and provides diagnostics for cardiovascular, neurological and eye disorders. Currently the company employs 11 employees and is based in Helsinki, Finland.

More information:

Tommi Lehtonen
Blueprint Genetics Oy

SOURCE Blueprint Genetics
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
2. Ultragenyx Relocates Company Headquarters to Support Operational Expansion
3. MediPendant™ to Return to Television on May 20th New Television Campaign - Company Provides MediPendant™ Update
4. Perrigo Company Will Release Third Quarter Fiscal 2012 Results On May 8, 2012
5. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
6. DiversityInc Names Lilly a Top Company for Diversity
7. International Drug & Explosives Detection Company IDenta Corp. Releases Information to OTC markets.
8. The Female Health Company Reports Second Quarter Operating Results
9. The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Gen-Probe Incorporated in Connection with the Sale of the Company to Hologic, Inc.
10. Perrigo Company to Present at the Bank of America Merrill Lynch 2012 Healthcare Conference
11. Judge Upholds $3.3 Million Judgment In Favor of Fox Insurance Company Against Former Pharmacy Benefit Manager
Post Your Comments:
(Date:11/30/2015)... Calif. , Nov. 30, 2015 /PRNewswire/ ... the norm in U.S. medical imaging is ... increasingly popular accountable care payer-provider contracts are ... and, in their wake, alter provider-vendor relationships. ... payments will push forward new purchasing frameworks ...
(Date:11/30/2015)... JERUSALEM , Nov. 30, 2015 Oramed ... company focused on the development of oral drug delivery ... investment agreements valued at up to $50,000,000 with Hefei Tianhui Incubator of ... Oramed,s oral insulin capsule, ORMD-0801, in China ... Macau . The agreements were signed ...
(Date:11/30/2015)... N.H. , Nov. 30, 2015 ... that it will feature its latest solutions for ... early identification of cancer at the Radiological Society ... Chicago from November 29 ... recent product advances including iReveal®, an automated breast ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... November 30, 2015 , ... ... announce the speakers for “Value-Based Payer-Provider Partnerships: Three Case Studies,” an upcoming ... value-based care arrangements: Essentia Health and UCare, MissionPoint Health Partners, and Intel ...
(Date:11/30/2015)... EMIGSVILLE, PA (PRWEB) , ... November 30, 2015 ... ... (CCMS) software provider, has verified that their Vasont Universal Integrator (VUI) extension unites ... handle creating, editing, and managing content as a continuous process with the latest ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... is one of a select few plastic surgeons in the New York City ... , SculpSure™ is the world’s first heat-induced laser treatment for fat loss in ...
(Date:11/30/2015)... ... November 30, 2015 , ... TransPack Volume 6 features 30 customizable transitions created ... web-styled transitions to wipes with blur & drop shadow options. Utilize the controls ... from one clip to the next with TransPack's easily customizable styles. , ...
(Date:11/30/2015)... , ... November 30, 2015 ... ... Inc. are pleased to announce their strategic partnership at the Radiological Society ... Transcription Service, Inc., and Winscribe, global providers of cutting-edge dictation and speech-enabled ...
Breaking Medicine News(10 mins):